Rentschler Biotechnologie, a Laupheim, Germany-based contract development and manufacturing organization for biopharmaceuticals, has opened a new biomanufacturing facility in Laupheim. The facility is equipped with two 3,000-liter stainless steel bioreactors for manufacturing cell culture-derived proteins and is complemented by directly connected equipment for protein purification. The system further increases Rentschler’s biomanufacturing capacity. A newly installed 2,000-liter single-use bioreactor came on line in 2015.

Proteins for clinical development of drug candidates as well as already approved drugs will be produced, at the expanded facility.

Rentschler is planning to  increase the size of its workforce by creating approximately 200 new jobs. The company is seeking a variety of skilled employees, including process engineers and laboratory technicians in bioprocess development and manufacturing as well as GMP experts.

Source: Rentschler Biotechnologie